Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Teng Zhou
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
ORCID:
0009-0004-8350-864X
Observed ORCID:
0009-0004-8350-864X
OpenAlex ID:
A5050773980
Therapeutic advances and application of PARP inhibitors in breast cancer
2025
·
Teng Zhou
, Jian Zhang
·
Translational Oncology
·
40
Efficacy of Trastuzumab Deruxtecan in HER2-Positive and HER2-Low Metastatic Breast Cancer: A Real-World Retrospective Cohort Study in China
2025
·
Yuxin Yan
, Yizi Jin
, et al.
·
Breast Cancer Targets and Therapy
·
4
PDF
Complex I protein NDUFB9 is a metabolic vulnerability in triple negative breast cancer brain metastases
2026
·
Mingxi Lin
, Zhexu Wen
, et al.
·
Nature Communications
·
2
PDF
AKAP13 regulates GLI1/ULK1 axis and drive tumor resistance to next-generation HER2-targeted therapies
2026
·
Qing Guo
, Xinyu Chen
, et al.
·
Oncogene
Data-driven precision prognostic stratification in breast cancer leptomeningeal metastasis: The BC-LGPA model and treatment refinement.
2026
·
Jian Zhang
, Yuxin Yan
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
5
Citation count:
46
H-index:
2
I10-index:
1
Year
Topic
Type